
    
      This is a Phase IV, multi-center, open label study that assesses the safety and tolerability
      of Iron Sucrose (Venofer) in subjects with CKD who require intravenous iron for the treatment
      of iron deficiency anemia (IDA) but cannot tolerate Ferumoxytol or Iron Dextran.
    
  